Akebia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.About AKBA
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders.
CEOJohn P. Butler
CEOJohn P. Butler
Employees181
Employees181
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2007
Founded2007
Employees181
Employees181
AKBA Key Statistics
Market cap449.97M
Market cap449.97M
Price-Earnings ratio-21.81
Price-Earnings ratio-21.81
Dividend yield—
Dividend yield—
Average volume3.49M
Average volume3.49M
High today$1.70
High today$1.70
Low today$1.65
Low today$1.65
Open price$1.67
Open price$1.67
Volume2.11M
Volume2.11M
52 Week high$4.08
52 Week high$4.08
52 Week low$1.45
52 Week low$1.45
Stock Snapshot
The current Akebia Therapeutics(AKBA) stock price is $1.66, with a market capitalization of 449.97M. The stock trades at a price-to-earnings (P/E) ratio of -21.81.
As of 2025-12-13, Akebia Therapeutics(AKBA) stock has fluctuated between $1.65 and $1.70. The current price stands at $1.66, placing the stock +0.6% above today's low and -2.4% off the high.
Akebia Therapeutics(AKBA) shares are trading with a volume of 2.11M, against a daily average of 3.49M.
During the past year, Akebia Therapeutics(AKBA) stock moved between $1.45 at its lowest and $4.08 at its peak.
During the past year, Akebia Therapeutics(AKBA) stock moved between $1.45 at its lowest and $4.08 at its peak.
People also own
Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.